University of Warwick

Aldenham Education Group Brings Current UK Prep School Head, Vicky Gocher, to Riyadh as Founding Head

Retrieved on: 
Dimanche, février 20, 2022
Arts Council England, History, KSA, Learning, Family, Time, Headmasters, Silver, Pupil, School, Parent, Education, Curriculum, The Good Schools Guide, AEG, Foundation, CTI Education Group, Leadership, Association, Culture, IAPS, Independent Association of Prep Schools, Artsmark, Headmasters' and Headmistresses' Conference, Partner (business rank), Child, Ageing, Caterham, GCC, Knowledge, Preparatory school, Conference, University of Warwick, HMC, Interior design, Medicine, Tutoring, Management, Aldenham, Charles Gocher

RIYADH, Saudi Arabia, Feb. 20, 2022 /PRNewswire/ -- Aldenham Education Group (Aldenham) is pleased to announce it is bringing Vicky Gocher, current head of Aldenham Prep in the UK, to Riyadh to serve as the Founding Head for the new Aldenham Prep Riyadh in Saudi Arabia. Having led, inspired and educated Aldenham's pupils and teaching staff in the UK for over a decade, the appointment of Gocher as Founding Head will ensure the new Riyadh school is built on the same foundations, principles and ethos as Aldenham in the UK. Opening in September 2022, Aldenham Prep Riyadh will cater to children aged 3-11 years and be the first owner-operated, truly integrated branch campus of a notable independent UK school in Riyadh and the greater GCC region. Announcements for Aldenham Senior School will follow later in the year.

Key Points: 
  • RIYADH, Saudi Arabia, Feb. 20, 2022 /PRNewswire/ --Aldenham Education Group (Aldenham) is pleased to announce it is bringing Vicky Gocher, current head of Aldenham Prep in the UK, to Riyadh to serve as the Founding Head for the new Aldenham Prep Riyadh in Saudi Arabia.
  • Before joining Aldenham, Gocher was previously Deputy Head at Caterham Prep School, a leading, co-educational day school, and holds an MA in Educational Leadership and Innovation from Warwick University.
  • Due to emigrate to the region before starting her new role in September 2022, Gocher shares her delight at founding the Riyadh school: "I am extremely excited to be coming to Saudi Arabia as the Founding Head of Aldenham Prep School Riyadh, after 10 years leading Aldenham Prep School in the UK.
  • Read more about Aldenham Riyadh here: https://www.aldenhamprepriyadh.com/
    Aldenham Education Group (Aldenham or AEG) is the exclusive commercial arm of the Aldenham Foundation, leading all international expansion efforts.

Ceylon Graphite’s Silicon Enhanced Vein Graphite Anode Material Significantly Increases Specific Discharging Capacity in Half Cell Lithium-Ion Battery Tests

Retrieved on: 
Mardi, février 1, 2022
Government, SDC, University of Warwick, Failure, University, TSX Venture Exchange, National Instrument 43-101, Risk factor, Silicon, IML, Technology, Graphite, CCY, Local government in Sri Lanka, WMG, Risk, Ampere, News, FSE, GLOBE, Acquisition, Industry, OTC, National instrument, Mining, CYL, Aluminium, Lithium

Ceylon Graphite conducted initial half cell testing for silicon enhanced vein graphite at WMG Battery Catapult, University of Warwick.

Key Points: 
  • Ceylon Graphite conducted initial half cell testing for silicon enhanced vein graphite at WMG Battery Catapult, University of Warwick.
  • Impressive 13% increase in discharging capacity was achieved for Ceylons natural vein graphite enhanced with core shell silicon additive compared to its baseline Ceylon Vein graphite material and commercial synthetic graphite.
  • In tests at a leading global, independent facility, Warwick University, performance of Ceylons vein graphite anode material was further improved by its core-shell silicon additive.
  • This is the first time in battery research history that commercial spherodized, silicon enhanced vein graphite materials were tested in a lithium-ion battery in a half cell.

Clover Appoints Nicholas Jackson, Ph.D., as President of Global Research and Development

Retrieved on: 
Mardi, février 1, 2022
Forward-looking statement, SCB-2019, University, Development, Sanofi Pasteur, Technology, Research, Pfizer, COVID-19, CpG, D, CEPI, Center, Hygiene, Global Research, University of Warwick, Vaccine, GLOBE, Bachelor of Science in Biomedical Engineering, Epidemic, Severe acute respiratory syndrome coronavirus 2, London School of Hygiene & Tropical Medicine, Tropical medicine, IAVI, Oxford Brookes University, GlaxoSmithKline, Pharmaceutical industry, Clover, Trimer, Science

(Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointment of Nicholas Jackson, Ph.D., as President of Global Research and Development.

Key Points: 
  • (Clover; HKEX: 02197), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, today announced the appointment of Nicholas Jackson, Ph.D., as President of Global Research and Development.
  • "I am honored to join Clover and look forward to helping expand its global R&D capabilities and innovative pipeline of vaccines and oncology therapies.
  • Prior to his work at CEPI, Dr. Jackson was Vice President, Head of Global Research for Sanofi Pasteur, responsible for leading vaccine research and early development activities globally.
  • Before Sanofi Pasteur, Nicholas held vaccine and immunotherapeutic development roles at Pfizer, IAVI and GlaxoSmithKline, where he oversaw R&D programs, global clinical trials and collaborations.

Nemaura Medical Appoints Dr. Arash Ghadar as Chief Operating Officer

Retrieved on: 
Lundi, janvier 10, 2022
Bachelor, Growth, Engineering, Industry, Area studies, Control engineering, Patient, Association, PMA, CE, Doctor of Philosophy, List of life sciences, CEO, CGM, Prediabetes, Ash, Company, Diabetes, Nasdaq, Artificial intelligence, University, Certification, Technical, GLOBE, Weight loss, University of Warwick, Medical device, Risk management, Data link, Nemaura Medical, Electronics, Biosensor

Loughborough, England, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(Nemaura or the Company), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the appointment of Dr. Arash (Ash) Ghadar as Chief Operating Officer.

Key Points: 
  • Loughborough, England, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (Nasdaq: NMRD)(Nemaura or the Company), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the appointment of Dr. Arash (Ash) Ghadar as Chief Operating Officer.
  • Ash will play an important role at Nemaura as we begin to scale up our manufacturing and distribution operations.
  • He brings over 20 years of product development, management and leadership experience spanning both business and technical disciplines.
  • Nemaura Medical Inc. is a medical technology company developing and commercializing non-invasive wearable diagnostic devices.

Lui Franciosi Examining The Green House Project and Related Models To Improve Senior Care

Retrieved on: 
Jeudi, janvier 6, 2022
Chronic pain, University, Bath, COVID-19, Green House Project, Project, Review, Research, YouTube, Green House, University of Warwick, Trust, Quality of life, University of British Columbia, Simon Fraser University, Meal, Lyme disease, CEO, Pfizer–BioNTech COVID-19 vaccine, Infection, Suggestion, Pharmacology, Master, GLOBE, Management

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that he will be examining The Green House Project as one of the most innovative models of senior care.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that he will be examining The Green House Project as one of the most innovative models of senior care.
  • Lui Franciosi states, This past year has been a challenging one for many seniors and their families who are within the traditional, institutional model of senior care.
  • There is a need to better understand if alternative models of senior care such as the Green House Project could improve quality of life and delivery of care, even within the current model without spending an enormous amount of money.
  • Lui Franciosi is a consultant with over 20 years of executive experience collected in the pharmaceutical and senior care industries.

Lui Franciosi Launches New Consultancy Website to Support Pharmaceutical Discovery and Development

Retrieved on: 
Jeudi, janvier 6, 2022
University, Review, Cros, CDA, University of Warwick, Investigational New Drug, University of British Columbia, Simon Fraser University, Electronic common technical document, CEO, Master, Pharmacology, GLOBE, Drug development, COO, Industry, Pharmaceutical industry, EU

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of his new consultancy website, Franciosi Consulting Ltd. to offer support and guidance for those working in pharmaceutical discovery and development.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is proud to announce the launch of his new consultancy website, Franciosi Consulting Ltd. to offer support and guidance for those working in pharmaceutical discovery and development.
  • Lui Franciosi has 20 years of experience in several different professional capacities, including operations management, clinical research, drug development, and project management.
  • Franciosi Consulting can advise or represent clients during dialogue with regulatory authorities in North & South America, the EU and Asia.
  • Dr. Lui Franciosi is a consultant with over 20 years of experience in the pharmaceutical industry.

Franciosi Consulting Reviewing the Use of Psilocybin for Treating Depression, Anxiety and Addiction

Retrieved on: 
Jeudi, janvier 6, 2022
Psilocybin, Smoking, Chronic pain, University, COVID-19, US Foods, Speech disorder, Review, Depression, Research, YouTube, Science, University of Warwick, University of British Columbia, Simon Fraser University, Lyme disease, History, Pfizer–BioNTech COVID-19 vaccine, Master, Pharmacology, FDA, Hallucinogen, GLOBE, Post-traumatic stress disorder, COO, Anxiety, Pharmaceutical industry

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi has been reviewing the science and history of psychedelic drugs for treating depression, anxiety and addiction.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi has been reviewing the science and history of psychedelic drugs for treating depression, anxiety and addiction.
  • The US Food and Drug Administration (FDA) has designated psilocybin as a breakthrough therapy for hard-to-treat depression and post-traumatic stress disorder.
  • For more information about Lui Franciosi and his company Franciosi Consulting Ltd., please visit https://franciosiconsulting.com/ or his YouTube Channel https://www.youtube.com/channel/UC7PSoeH8yN-HuLg5xFi5Qxw/ .
  • Lui Franciosi founded Franciosi Consulting Ltd. in 2015 and is the President and CEO.

Lui Franciosi To Monitor the Safety and Efficacy of Nebulized Heparin for the Treatment of COVID-19

Retrieved on: 
Jeudi, janvier 6, 2022
Chronic pain, University, Safety, COVID-19, Severe acute respiratory syndrome coronavirus 2, Lung, Review, Research, Patient, YouTube, University of Warwick, COVID, University of British Columbia, Simon Fraser University, Lyme disease, Diffuse alveolar damage, Pfizer–BioNTech COVID-19 vaccine, Yolk sac, Master, Suggestion, Pharmacology, Mortality, GLOBE, Heparin, Pharmaceutical industry

VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi will be monitoring the safety and efficacy of nebulized heparin for the treatment of SARS-CoV-2, i.e., COVID-19.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 06, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi will be monitoring the safety and efficacy of nebulized heparin for the treatment of SARS-CoV-2, i.e., COVID-19.
  • For more information about Lui Franciosi and his company Franciosi Consulting Ltd., please visit https://franciosiconsulting.com/ or his YouTube Channel https://www.youtube.com/channel/UC7PSoeH8yN-HuLg5xFi5Qxw/ .
  • Lui Franciosi is a pharmacologist and consultant with over 20 years of executive experience collected in the pharmaceutical and senior care industries.
  • He also studied business at the University of Warwick in the U.K. Lui Franciosi founded Franciosi Consulting Ltd. in 2015 and is the President and CEO.

Lui Franciosi To Assess the Safety and Efficacy of a New Dementia Treatment

Retrieved on: 
Mercredi, janvier 5, 2022
Alzheimer Society of Canada, Chronic pain, University, Safety, COVID-19, Food, Research, YouTube, University of Warwick, Alzheimer Society of Ontario, Dementia, University of British Columbia, Simon Fraser University, Lyme disease, Disease, Pfizer–BioNTech COVID-19 vaccine, Master, Pharmacology, FDA, GLOBE, Drug development, Pharmaceutical industry

VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing and monitoring the safety and efficacy of the new dementia treatment - aducanumab.

Key Points: 
  • VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Lui Franciosi is pleased to announce that Franciosi Consulting Ltd. will be reviewing and monitoring the safety and efficacy of the new dementia treatment - aducanumab.
  • Lui Franciosi states, This drug binds specifically to aggregated forms or plaques of a protein called beta-amyloid, which is the major driver of Alzheimers disease.
  • For more information about Lui Franciosi and his company Franciosi Consulting Ltd., please visit https://franciosiconsulting.com/ or his YouTube Channel https://www.youtube.com/channel/UC7PSoeH8yN-HuLg5xFi5Qxw/ .
  • He also studied business at the University of Warwick in the U.K. Lui Franciosi founded Franciosi Consulting Ltd. in 2015 and is the President and CEO.

Lui Franciosi Examining the Danish Approach to Seniors Care and Housing

Retrieved on: 
Mercredi, janvier 5, 2022
Chronic pain, Housing, University, COVID-19, Review, Research, YouTube, University of Warwick, COVID, University of British Columbia, Simon Fraser University, Lyme disease, CEO, Pfizer–BioNTech COVID-19 vaccine, Master, Pharmacology, Mortality, GLOBE, Publishing, Health insurance

With the large confirmed COVID cases and mortality numbers within care homes, it has been become clear that Canada needs to consider other models of seniors care and housing.

Key Points: 
  • With the large confirmed COVID cases and mortality numbers within care homes, it has been become clear that Canada needs to consider other models of seniors care and housing.
  • Lui Franciosi states, Danish seniors are not placed into care until they need more than 20 hours of care per day.
  • For more information about Lui Franciosi and his company Franciosi Consulting Ltd., please visit https://franciosiconsulting.com/ or his YouTube Channel https://www.youtube.com/channel/UC7PSoeH8yN-HuLg5xFi5Qxw/ .
  • Lui Franciosi is a consultant with over 20 years of executive experience collected in the pharmaceutical and senior care industries.